Impact of a Patient Support Program on time to discontinuation of adalimumab in Australian adult patients with immune-mediated inflammatory diseases-an observational study von Jones, Graeme, Calao, Miriam, Begun, Jakob, Sin, Shirley, Kouhkamari, Mahsa H, Young, Elisa, Fernández-Peñas, Pablo, Watts, Alan, Östör, Andrew J

Volltext

Pulmonary adverse events of small molecule JAK inhibitors in autoimmune disease: systematic review and meta-analysis von Khoo, Jun K, Barnes, Hayley, Key, Seraphina, Glaspole, Ian N, Östör, Andrew J

Volltext

Time to flare in giant cell arteritis and polymyalgia rheumatica: analysis from a single‐centre Australian practice von Bhurani, Mansi, Hall, Stephen, Gibson, Andrew, Östör, Andrew J. K.

Volltext

Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice von Bykerk, Vivian P, Östör, Andrew J K, Alvaro-Gracia, José, Pavelka, Karel, Ivorra, José Andrés Román, Graninger, Winfried, Bensen, William, Nurmohamed, Michael T, Krause, Andreas, Bernasconi, Corrado, Stancati, Andrea, Sibilia, Jean

Volltext

Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution von Kuek, Annabel, Hazleman, Brian L, Östör, Andrew J K

Volltext

Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review von Gout, Taras, Östör, Andrew J. K., Nisar, Muhammad K.

Volltext

Non-infectious pulmonary complications of newer biological agents for rheumatic diseases-a systematic literature review von Hadjinicolaou, Andreas V., Nisar, Muhammad K., Bhagat, Shweta, Parfrey, Helen, Chilvers, Edwin R., Östör, Andrew J. K.

Volltext

Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom von Nisar, Muhammad K., Rafiq, Aneesa, Östör, Andrew J. K.

Volltext

Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial von Edwards, Christopher J, Östör, Andrew J K, Naisbett-Groet, Barbara, Kiely, Patrick

Volltext

Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort von Nikiphorou, Elena, Negoescu, Andra, Fitzpatrick, John D., Goudie, Calum T., Badcock, Andrew, Östör, Andrew J. K., Malaviya, Anshuman P.

Volltext

Interleukin-6 and cytochrome-P450, reason for concern? von Kim, Sooha, Östör, Andrew J. K., Nisar, Muhammad K.

Volltext

Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies von Cooles, Faye A H, Anderson, Amy E, Drayton, Tracey, Harry, Rachel A, Diboll, Julie, Munro, Lee, Thalayasingham, Nishanthi, Östör, Andrew J K, Isaacs, John D

Volltext

Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension von van der Heijde, Désirée, Deodhar, Atul, Maksymowych, Walter P, Sieper, Joachim, Van den Bosch, Filip, Kim, Tae-Hwan, Kishimoto, Mitsumasa, Östör, Andrew J, Combe, Bernard, Sui, Yunxia, Duan, Yuanyuan, Wung, Peter K, Song, In-Ho

Volltext

Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments:... von Bykerk, Vivian P., Östör, Andrew J. K., Alvaro-Gracia, José, Pavelka, Karel, Ivorra, José Andrés Román, Graninger, Winfried, Bensen, William, Nurmohamed, Michael T., Krause, Andreas, Bernasconi, Corrado, Aassi, Maher, Sibilia, Jean

Volltext

Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to cli... von Bykerk, Vivian P., Östör, Andrew J. K., Alvaro-Gracia, José, Pavelka, Karel, Román Ivorra, José Andrés, Nurmohamed, Michael T., Luder, Yves, Sidiropoulos, Paris N. M., Devenport, Jenny, Sibilia, Jean

Volltext

The prevalence and impact of polypharmacy in rheumatology von Lewis, Justin, Östör, Andrew J K

Volltext

Update on biosimilars in rheumatology von Rischin, Adam, Östör, Andrew J. K.

Volltext

Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis von Mäki‐Petäjä, Kaisa M., Day, Lisa, Cheriyan, Joseph, Hall, Frances C., Östör, Andrew J. K., Shenker, Nicholas, Wilkinson, Ian B.

Volltext

What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence von Nisar, Muhammad K., Masood, Falak, Cookson, Paul, Sansome, Alison, Östör, Andrew J. K.

Volltext

Biologic agents for rheumatoid arthritis-negotiating the NICE technology appraisals von Kiely, Patrick D. W., Deighton, Chris, Dixey, Josh, Östör, Andrew J. K.

Volltext